Stockscreener 앱 받기
0.365
2.13%
0.0076
시간 외 거래:
.36
-0.005
-1.37%
전일 마감가:
$0.3574
열려 있는:
$0.3599
하루 거래량:
1.36M
Relative Volume:
0.20
시가총액:
$10.39M
수익:
$9.37M
순이익/손실:
$-8.45M
주가수익비율:
-0.4506
EPS:
-0.81
순현금흐름:
$-7.27M
1주 성능:
+27.27%
1개월 성능:
+54.40%
6개월 성능:
-45.93%
1년 성능:
-85.10%
1일 변동 폭
$0.352
$0.3736
1주일 범위
$0.27
$0.3736
52주 변동 폭
$0.1639
$2.9893
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.365 | 8.16M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
What analysts say about bioAffinity Technologies Inc. stockRapid portfolio appreciation - Autocar Professional
What drives bioAffinity Technologies Inc. stock priceHigh-yield portfolio picks - Autocar Professional
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentPowerful profit generation - PrintWeekIndia
What drives bioAffinity Technologies Inc. Equity Warrant stock priceHigh-performance investment picks - Autocar Professional
Is bioAffinity Technologies Inc. a good long term investmentOutstanding capital growth - Autocar Professional
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockExponential wealth increase - Autocar Professional
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com
Why bioAffinity Technologies Inc. stock is on top investor watchlistsFree Investment Community - Newser
bioAffinity Technologies Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com
Published on: 2025-07-17 23:17:46 - Newser
bioAffinity Technologies Secures Chinese Patent for Lung Cancer Detection - The Globe and Mail
Before You Invest, Make Sure You Check This BioAffinity Technologies Inc (NASDAQ: BIAF) Analysis - Stocksregister
Why bioAffinity Technologies Inc. Equity Warrant stock attracts strong analyst attentionExpert Backed Predictions - Newser
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
How bioAffinity Technologies Inc. Equity Warrant stock performs during market volatilityAI Powered Stock Call - Newser
bioAffinity receives patent award for lung cancer diagnostic in China. - AInvest
Why bioAffinity Technologies Inc. stock attracts strong analyst attentionFree Best Stocks to Buy Today - Newser
How bioAffinity Technologies Inc. stock performs during market volatilityHigh Win Rate Stock Ideas - Newser
What makes bioAffinity Technologies Inc. stock price move sharplyFree Predictions - Newser
BioAffinity receives China patent for noninvasive lung cancer diagnostic - TipRanks
What makes bioAffinity Technologies Inc. Equity Warrant stock price move sharplyTargeted 200 Percent Gain - Newser
bioAffinity secures Australian patent for lung cancer test - MSN
bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 10.2% – Should You Sell? - Defense World
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging - Business Wire
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies - Yahoo Finance
Top Research Reports for Meta Platforms, ServiceNow & Booking - MSN
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference - FinancialContent
bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy - Business Wire
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.04%
1.25%
자본화:
|
볼륨(24시간):